Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-1841.83%EBITDA Margin
VS
Market
Sector
Industry
History
$ 0.46Close
$ 0.41 - $ 3.18 52-Week Range
Ticker Information
Ticker
RANICompany Name
RANI THERAPEUTICS HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQRANI THERAPEUTICS HOLDINGS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RANI - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -22.1M | -1841.83% | $ 1.2M |
| 3/31/2025 | $ -22.18M | -1848.33% | $ 1.2M |
| 12/31/2024 | $ -22.15M | -2154.47% | $ 1.03M |
| 9/30/2024 | $ -20.38M | 0% | $ 0 |
| 6/30/2024 | $ -23.45M | 0% | $ 0 |
| 3/31/2024 | $ -25.87M | 0% | $ 0 |
| 12/31/2023 | $ -27.02M | 0% | $ 0 |
| 9/30/2023 | $ -29.41M | 0% | $ 0 |
| 6/30/2023 | $ -29.36M | 0% | $ 0 |
| 3/31/2023 | $ -37.3M | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- RANI THERAPEUTICS HOLDINGS INC's latest trailing twelve months (TTM) EBITDA % stands at -3453.46%.
- Over the past 5 years, RANI THERAPEUTICS HOLDINGS INC's average EBITDA % has been -2382.1%.
- The median EBITDA % for RANI THERAPEUTICS HOLDINGS INC during this period was -2035.72%
- RANI THERAPEUTICS HOLDINGS INC reached its highest EBITDA % over the past 5 years at -1841.83%.
- The lowest EBITDA % recorded by RANI THERAPEUTICS HOLDINGS INC in the same timeframe -3453.46%
RANI THERAPEUTICS HOLDINGS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for RANI THERAPEUTICS HOLDINGS INC is calculated as follows: EBITDA [ $ -15.96M ] / Revenues [ $ 462K ]
(=) EBITDA % [ -3453.46% ] RANI - EBITDA Margin, Last 5 years
-3453.46%
Minimum
Dec 31, 2020
-1841.83%
Maximum
Jun 30, 2025
-2382.1%
Average
-2035.72%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.33% |
| max | 97.24% |
| average | 16.2% |
| median | 14.74% |
| std | 26.73% |